Table 5.
T1a | T1b | Odds ratio | 95% CI | |
You et al[3] | 1/27 (3.7) | 0/25 | 0.510 | 0.39-0.67 |
Shirai et al[26] | 2/78 (2.6) | 0/11 | 0.874 | 0.81-0.95 |
Wakai et al[10] | 1/13 (7.7) | 0/2 | 0.923 | 0.79-1.08 |
Z'graggen et al[29] | 0/3 | 1/6 (16.7) | 1.200 | 0.84-1.72 |
Wagholikar et al[7] | 0/2 | 5/12 (41.7) | 1.286 | 0.91-1.82 |
Goetze et al[5] | 0/21 | 14/72 (19.4) | 1.362 | 1.19-1.56 |
Cangemi et al[27] | 0/4 | 5/11 (45.4) | 1.667 | 1.01-2.77 |
Kim et al[17] | 0/10 | 1/9 (11.1) | 2.250 | 1.34-3.77 |
Chan et al[12] | 1/14 (7.1) | 3/19 (15.8) | 2.438 | 0.23-26.29 |
Otero et al[32] | 0/25 | 9/26 (34.6) | 2.471 | 1.71-3.57 |
Ouchi et al[11] | 1/8 (12.5) | 3/7 (42.9) | 5.250 | 0.40-68.94 |
Ouchi et al[18] | 1/167 (0.6) | 3/67 (4.5) | 7.781 | 0.79-76.19 |
Cucinotta et al[4] | 1/5 (20) | 6/7 (85.7) | 24.000 | 1.14-505.2 |
Wakai et al[6] | 0 | 2/25 (8.0) |